Page 7 - ARNM-1-2

Advances in Radiotherapy &

Nuclear Medicine

EDITORIAL
Advances in Radiotherapy and Nuclear Medicine

(ARNM): Leading the charge in oncological
innovation

Tsair-Fwu Lee 1,2,3 *
1 Medical Physics and Informatics Laboratory of Electronics Engineering, National Kaohsiung
University of Science and Technology, Kaohsiung, Taiwan
2 Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
3 Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University,
Kaohsiung, Taiwan

An excellent journal focusing on cancer topics is an instrumental element in enhancing
innovation in cancer research. Given the dynamic landscape of cancer treatment, the
Advances in Radiotherapy & Nuclear Medicine (ARNM) provides an indispensable resource,
steering the course of research and clinical practices in radiation oncology, physics, and
biology. This peer-reviewed, open-access journal transcends its role as a mere repository of
knowledge; instead, it acts as a pioneering force propelling the medical community toward
groundbreaking discoveries and innovative treatments in the relentless battle against cancer.
In alignment with our goal of bridging the chasm between research and clinical
application, ARNM is unmatched in its commitment to advancing our understanding
of radiotherapy. It functions as a critical platform for oncologists, physicians, and
researchers, creating an ecosystem where novel ideas and research findings in both
fundamental and clinical research are not merely shared but rigorously scrutinized and
honed. This melding of theory with practice is vital for translating complex research into
*Corresponding author:
Tsair-Fwu Lee tangible, patient-centric benefits.
(tflee@nkust.edu.tw) ARNM has a comprehensive and multifaceted scope, encompassing a wide array of
Citation: Lee T, 2023, Advances in radiation oncology topics:
Radiotherapy and Nuclear Medicine (i) Conventional radiotherapy: The journal highlights advancements in traditional
(ARNM): Leading the charge
in oncological innovation. Adv radiotherapy, affirming its ongoing relevance in modern clinical practice.
Radiother Nucl Med, 1(2): 2615 (ii) Stereotactic body radiation therapy and brachytherapy: ARNM delves deeply into
https://doi.org/10.36922/arnm.2615 these targeted therapy forms, emblematic of precision in cancer treatment .
[1]
Received: January 2, 2024 (iii) Boron neutron capture therapy and particle therapy: The journal explores these
innovative treatments, showcasing their potential to provide more effective, less
Published Online: January 10,
[2]
2024 invasive options for patients .
(iv) Targeted and immunotherapy (TI): By discussing the latest developments in TI,
Copyright: © 2024 Author(s).
This is an Open-Access article ARNM emphasizes the critical role of personalized medicine in oncology.
distributed under the terms of the (v) Combined modality therapy (CMT): The journal’s coverage of CMT, including
Creative Commons Attribution heat therapy, electric field therapy, and nursing technology, reflects its dedication to
License, permitting distribution,
[3]
and reproduction in any medium, holistic treatment approaches .
provided the original work is (vi) Radiation biology and radiation physics: ARNM offers fundamental insights into
properly cited. underlying principles of radiotherapy, essential for fostering innovation.
Publisher’s Note: AccScience (vii) Innovative radiation technology, positron emission tomography,
Publishing remains neutral with radiopharmaceuticals, and single-photon emission computed tomography: The
regard to jurisdictional claims in
published maps and institutional journal remains at the vanguard of technological advancements, providing crucial
[4]
affiliations. insights into these progressive techniques .

Volume 1 Issue 2 (2023) 1 https://doi.org/10.36922/arnm.2615